Table 1.

Administration of cyclohexamide (CH) inhibits NMD in MEFs from Coq9^Q95X and Coq9^R239X mice

	Coq9 mRNA (CH-treated/untreated)
Coq9+/+	1.54 ± 0.12
Coq9Q95X	5.47 ± 1.14*
Coq9R239X	21.44 ± 6.8**,##

The results are represented as fold increase of Coq9 mRNA levels after cyclohexamide administration. Data are expressed as the mean ± SD of five experiments in triplicates per group. One-way ANOVA with a Tukey post hoc test.

^*P < 0.05;

^**P < 0.01; Coq9^Q95X and Coq9^R239X mice versus Coq9^+/+ mice.

^##P < 0.01; Coq9^Q95X versus Coq9^R239X mice. One-way ANOVA for comparison between the three experimental groups: P = 0.0022.